These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19379730)

  • 1. Increased protein carbonylation of red blood cell membrane in diabetic retinopathy.
    Margetis PI; Antonelou MH; Petropoulos IK; Margaritis LH; Papassideri IS
    Exp Mol Pathol; 2009 Aug; 87(1):76-82. PubMed ID: 19379730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy.
    Yamaguchi M; Nakamura N; Nakano K; Kitagawa Y; Shigeta H; Hasegawa G; Ienaga K; Nakamura K; Nakazawa Y; Fukui I; Obayashi H; Kondo M
    Diabet Med; 1998 Jun; 15(6):458-62. PubMed ID: 9632118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
    Pan HZ; Zhang H; Chang D; Li H; Sui H
    Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing lipid peroxidation stress of erythrocyte membrane by alpha-tocopherol nicotinate plays an important role in improving blood rheological properties in type 2 diabetic patients with retinopathy.
    Chung TW; Yu JJ; Liu DZ
    Diabet Med; 1998 May; 15(5):380-5. PubMed ID: 9609359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.
    Lee JH; Lee W; Kwon OH; Kim JH; Kwon OW; Kim KH; Lim JB
    Ann Clin Lab Sci; 2008; 38(4):361-7. PubMed ID: 18988929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma apelin and asymmetric dimethylarginine levels in type 2 diabetic patients with diabetic retinopathy.
    Yonem A; Duran C; Unal M; Ipcioglu OM; Ozcan O
    Diabetes Res Clin Pract; 2009 Jun; 84(3):219-23. PubMed ID: 19344973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte membrane anionic content and urinary glycosaminoglycan excretion in type 1 diabetes: association with retinopathy.
    Yenice O; Kazokoğlu H; Ozcan E; Yüksel M; Adigüzel G; Haklar G; Yavuz DG
    Curr Eye Res; 2006 Nov; 31(11):975-81. PubMed ID: 17114123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
    Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
    Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma carotenoids and diabetic retinopathy.
    Brazionis L; Rowley K; Itsiopoulos C; O'Dea K
    Br J Nutr; 2009 Jan; 101(2):270-7. PubMed ID: 18554424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
    Gustavsson C; Agardh E; Bengtsson B; Agardh CD
    J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorheological disorders in patients with diabetic retinopathies].
    Bakhritdinova FA
    Vestn Oftalmol; 1996; 112(2):33-5. PubMed ID: 9045487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erytrocyte membrane anionic charge in type 2 diabetic patients with retinopathy.
    Budak Y; Demirci H; Akdogan M; Yavuz D
    BMC Ophthalmol; 2004 Oct; 4():14. PubMed ID: 15473902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluidity and fatty acid components of erythrocyte membranes in diabetic retinopathy.
    Yang G; Qiu H; Wang S; Deng H; Zhang S; Li L
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):407-12. PubMed ID: 10862451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein, C-reactive protein and oxidative stress parameters in dyslipidemic type 2 diabetic patients treated or not with simvastatin.
    Manfredini V; Biancini GB; Vanzin CS; Dal Vesco AM; Wayhs CA; Peralba Mdo C; Vargas CR
    Arch Med Res; 2010 Feb; 41(2):104-9. PubMed ID: 20470939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
    Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
    J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of adrenomedullin, a vasoactive peptide, in type 2 diabetic patients with and without retinopathy.
    Caliumi C; Balducci S; Petramala L; Cotesta D; Zinnamosca L; Cianci R; Di Donato D; Vingolo EM; Fallucca F; Letizia C
    Minerva Endocrinol; 2007 Jun; 32(2):73-8. PubMed ID: 17557032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
    Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
    Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.